MMI-0100

MMI-0100 is a cell-permeant peptide inhibitor of mitogen activated protein kinase activated protein kinase II (MK2). MMI-0100 reduces intimal hyperplasia ex vivo and in vivo. MMI-0100 suppresses IL-6 expression without effect on IL-8 expression. MMI-0100 suppresses fibrotic processes such as vein graft disease.
Read more
€0.00 (tax incl.)
Reference:
HY-P3412
Product Details
HY-P3412

Data sheet

Size
Multiple sizes
Reactivity
MAPKAPK2 (MK2)
Application
COVID-19-immunoregulation
CAS
1039342-24-9

Menu

Settings